Click here to go to the previous page
Genitourinary II — Hypofractionation and Hormonal Therapy
Program Code:
SST
Date:
Wednesday, November 4, 2009
SPEAKER(S):
Click the plus sign to see more detailed information
about each speaker.
Over the course of my career I have published 78 peer reviewed manuscripts on genito-urinary malignancies, 70 of these being on prostate cancer, and 51 as either first or co-principle author. My research interests have covered many aspects of prostate cancer, including the use of intermittent androgen suppression, the pathology of post radiation prostate biopsies, the use of neoadjuvant hormonal therapy combined with radiation therapy, post brachytherapy PSA kinetics, predictors of urinary sequelae after brachytherapy, critical organ dosimetry, and quality of life after both external beam radiotherapy and brachytherapy. I have been the principal investigator in multi-institutional trials run by NCIC, RTOG and ACOSOG.
|
Arthur Hung, M.D., Oregon Health Sciences University